Ignite Creation Date:
2025-12-25 @ 3:46 AM
Ignite Modification Date:
2026-05-12 @ 9:55 PM
Study NCT ID:
NCT01030302
Status:
COMPLETED
Last Update Posted:
2013-03-08
First Post:
2009-10-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Retreatment Study With Bortezomib for Multiple Myeloma
Sponsor:
Janssen Korea, Ltd., Korea
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CR015814
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None